ICU Medical, Inc. (ICUI)
USD 154.07
(-1.97%)
USD 154.07
(-1.97%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.45 Billion USD | 0.41% |
| 2022 | 1.44 Billion USD | 384.49% |
| 2021 | -507.78 Million USD | -47.63% |
| 2020 | -343.95 Million USD | -47.99% |
| 2019 | -232.41 Million USD | 32.59% |
| 2018 | -344.78 Million USD | -18.86% |
| 2017 | -290.07 Million USD | 34.83% |
| 2016 | -445.08 Million USD | -32.4% |
| 2015 | -336.16 Million USD | -21.88% |
| 2014 | -275.81 Million USD | -22.03% |
| 2013 | -226.02 Million USD | -53.86% |
| 2012 | -146.9 Million USD | -47.5% |
| 2011 | -99.59 Million USD | -26.3% |
| 2010 | -78.85 Million USD | -53.86% |
| 2009 | -51.24 Million USD | 7.99% |
| 2008 | -55.69 Million USD | -607.43% |
| 2007 | -7.87 Million USD | 40.14% |
| 2006 | -13.15 Million USD | -91.9% |
| 2005 | -6.85 Million USD | -22.04% |
| 2004 | -5.61 Million USD | -214.27% |
| 2003 | -1.78 Million USD | 57.09% |
| 2002 | -4.16 Million USD | -6.77% |
| 2001 | -3.9 Million USD | -100.57% |
| 2000 | -1.94 Million USD | -2.37% |
| 1999 | -1.9 Million USD | 5.0% |
| 1998 | -2 Million USD | 33.33% |
| 1997 | -3 Million USD | -42.86% |
| 1996 | -2.1 Million USD | 92.93% |
| 1995 | -29.7 Million USD | -4850.0% |
| 1994 | -600 Thousand USD | 66.67% |
| 1993 | -1.8 Million USD | 35.71% |
| 1992 | -2.8 Million USD | -16.67% |
| 1991 | -2.4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.43 Billion USD | -1.01% |
| 2024 Q2 | 1.37 Billion USD | -4.12% |
| 2023 FY | 1.45 Billion USD | 0.41% |
| 2023 Q4 | 1.45 Billion USD | 0.89% |
| 2023 Q3 | 1.43 Billion USD | -0.52% |
| 2023 Q2 | 1.44 Billion USD | 1.32% |
| 2023 Q1 | 1.42 Billion USD | -1.26% |
| 2022 Q4 | 1.44 Billion USD | -3.28% |
| 2022 Q3 | 1.49 Billion USD | 0.27% |
| 2022 Q1 | 1.42 Billion USD | 380.17% |
| 2022 FY | 1.44 Billion USD | 384.49% |
| 2022 Q2 | 1.48 Billion USD | 4.7% |
| 2021 FY | -507.78 Million USD | -47.63% |
| 2021 Q2 | -413.27 Million USD | -10.66% |
| 2021 Q3 | -473.21 Million USD | -14.51% |
| 2021 Q4 | -507.78 Million USD | -7.3% |
| 2021 Q1 | -373.45 Million USD | -8.58% |
| 2020 Q3 | -297.75 Million USD | -23.39% |
| 2020 Q1 | -269.55 Million USD | -15.98% |
| 2020 Q2 | -241.31 Million USD | 10.48% |
| 2020 FY | -343.95 Million USD | -47.99% |
| 2020 Q4 | -343.95 Million USD | -15.52% |
| 2019 Q3 | -279 Million USD | -9.68% |
| 2019 Q4 | -232.41 Million USD | 16.7% |
| 2019 Q1 | -257.43 Million USD | 25.33% |
| 2019 Q2 | -254.39 Million USD | 1.18% |
| 2019 FY | -232.41 Million USD | 32.59% |
| 2018 FY | -344.78 Million USD | -18.86% |
| 2018 Q1 | -254.53 Million USD | 12.25% |
| 2018 Q3 | -316.88 Million USD | -2.52% |
| 2018 Q2 | -309.09 Million USD | -21.44% |
| 2018 Q4 | -344.78 Million USD | -8.8% |
| 2017 Q3 | -225.61 Million USD | -35.98% |
| 2017 Q2 | -165.92 Million USD | -30.79% |
| 2017 FY | -290.07 Million USD | 34.83% |
| 2017 Q4 | -290.07 Million USD | -28.57% |
| 2017 Q1 | -126.86 Million USD | 71.5% |
| 2016 Q4 | -445.08 Million USD | -37.81% |
| 2016 Q3 | -322.96 Million USD | 13.39% |
| 2016 FY | -445.08 Million USD | -32.4% |
| 2016 Q1 | -347.37 Million USD | -3.33% |
| 2016 Q2 | -372.89 Million USD | -7.35% |
| 2015 Q4 | -336.16 Million USD | 5.4% |
| 2015 Q1 | -308.53 Million USD | -11.86% |
| 2015 Q2 | -331.09 Million USD | -7.31% |
| 2015 FY | -336.16 Million USD | -21.88% |
| 2015 Q3 | -355.36 Million USD | -7.33% |
| 2014 FY | -275.81 Million USD | -22.03% |
| 2014 Q4 | -275.81 Million USD | -9.34% |
| 2014 Q3 | -252.24 Million USD | -6.9% |
| 2014 Q1 | -227.62 Million USD | -0.71% |
| 2014 Q2 | -235.95 Million USD | -3.66% |
| 2013 Q3 | -188.03 Million USD | -10.22% |
| 2013 Q2 | -170.58 Million USD | -10.32% |
| 2013 Q1 | -154.63 Million USD | -5.26% |
| 2013 Q4 | -226.02 Million USD | -20.21% |
| 2013 FY | -226.02 Million USD | -53.86% |
| 2012 FY | -146.9 Million USD | -47.5% |
| 2012 Q4 | -146.9 Million USD | -15.19% |
| 2012 Q3 | -127.52 Million USD | -4.91% |
| 2012 Q2 | -121.56 Million USD | 0.44% |
| 2012 Q1 | -122.1 Million USD | -22.61% |
| 2011 Q4 | -99.59 Million USD | -48.78% |
| 2011 FY | -99.59 Million USD | -26.3% |
| 2011 Q1 | -71.11 Million USD | 9.81% |
| 2011 Q2 | -87.36 Million USD | -22.86% |
| 2011 Q3 | -66.93 Million USD | 23.38% |
| 2010 Q4 | -78.85 Million USD | -20.07% |
| 2010 Q3 | -65.67 Million USD | -14.01% |
| 2010 Q2 | -57.6 Million USD | -34.27% |
| 2010 Q1 | -42.9 Million USD | 16.29% |
| 2010 FY | -78.85 Million USD | -53.86% |
| 2009 Q4 | -51.24 Million USD | 3.78% |
| 2009 Q3 | -53.25 Million USD | 14.9% |
| 2009 FY | -51.24 Million USD | 7.99% |
| 2009 Q2 | -62.58 Million USD | 8.0% |
| 2009 Q1 | -68.02 Million USD | -22.14% |
| 2008 Q3 | -61.57 Million USD | 22.65% |
| 2008 Q2 | -79.6 Million USD | -111.75% |
| 2008 Q4 | -55.69 Million USD | 9.55% |
| 2008 FY | -55.69 Million USD | -607.43% |
| 2008 Q1 | -37.59 Million USD | -377.52% |
| 2007 Q2 | -9.25 Million USD | 0.53% |
| 2007 Q4 | -7.87 Million USD | -15.68% |
| 2007 FY | -7.87 Million USD | 40.14% |
| 2007 Q1 | -9.3 Million USD | 29.25% |
| 2007 Q3 | -6.8 Million USD | 26.48% |
| 2006 FY | -13.15 Million USD | -91.9% |
| 2006 Q4 | -13.15 Million USD | -175.4% |
| 2006 Q1 | -9.17 Million USD | -33.81% |
| 2006 Q2 | -6.79 Million USD | 25.94% |
| 2006 Q3 | -4.77 Million USD | 29.68% |
| 2005 Q1 | -6.45 Million USD | -14.89% |
| 2005 Q3 | -9.62 Million USD | -39.95% |
| 2005 Q4 | -6.85 Million USD | 28.77% |
| 2005 FY | -6.85 Million USD | -22.04% |
| 2005 Q2 | -6.87 Million USD | -6.57% |
| 2004 FY | -5.61 Million USD | -214.27% |
| 2004 Q4 | -5.61 Million USD | 8.74% |
| 2004 Q3 | -6.15 Million USD | -88.77% |
| 2004 Q2 | -3.26 Million USD | 14.17% |
| 2004 Q1 | -3.79 Million USD | -112.53% |
| 2003 Q1 | -4.12 Million USD | 0.86% |
| 2003 Q4 | -1.78 Million USD | 68.31% |
| 2003 FY | -1.78 Million USD | 57.09% |
| 2003 Q3 | -5.63 Million USD | -25.23% |
| 2003 Q2 | -4.5 Million USD | -9.06% |
| 2002 FY | -4.16 Million USD | -6.77% |
| 2002 Q4 | -4.16 Million USD | 20.95% |
| 2002 Q3 | -5.26 Million USD | -231.38% |
| 2002 Q2 | -1.59 Million USD | 65.18% |
| 2002 Q1 | -4.56 Million USD | -17.05% |
| 2001 Q1 | -1.7 Million USD | 12.29% |
| 2001 Q4 | -3.9 Million USD | -72.53% |
| 2001 FY | -3.9 Million USD | -100.57% |
| 2001 Q3 | -2.26 Million USD | 32.59% |
| 2001 Q2 | -3.35 Million USD | -96.6% |
| 2000 FY | -1.94 Million USD | -2.37% |
| 2000 Q4 | -1.94 Million USD | 8.86% |
| 2000 Q3 | -2.13 Million USD | 53.61% |
| 2000 Q2 | -4.6 Million USD | -91.83% |
| 2000 Q1 | -2.39 Million USD | -26.21% |
| 1999 Q4 | -1.9 Million USD | 50.0% |
| 1999 Q1 | -3.9 Million USD | -95.0% |
| 1999 Q3 | -3.8 Million USD | -90.0% |
| 1999 FY | -1.9 Million USD | 5.0% |
| 1999 Q2 | -2 Million USD | 48.72% |
| 1998 Q3 | -3.2 Million USD | 11.11% |
| 1998 FY | -2 Million USD | 33.33% |
| 1998 Q1 | -3.3 Million USD | -10.0% |
| 1998 Q2 | -3.6 Million USD | -9.09% |
| 1998 Q4 | -2 Million USD | 37.5% |
| 1997 Q3 | -4.2 Million USD | -121.05% |
| 1997 Q1 | -2.1 Million USD | 0.0% |
| 1997 Q4 | -3 Million USD | 28.57% |
| 1997 Q2 | -1.9 Million USD | 9.52% |
| 1997 FY | -3 Million USD | -42.86% |
| 1996 Q1 | -31.5 Million USD | -6.06% |
| 1996 Q2 | -34.1 Million USD | -8.25% |
| 1996 Q3 | -35.1 Million USD | -2.93% |
| 1996 FY | -2.1 Million USD | 92.93% |
| 1996 Q4 | -2.1 Million USD | 94.02% |
| 1995 Q2 | -300 Thousand USD | 70.0% |
| 1995 Q1 | -1 Million USD | -66.67% |
| 1995 FY | -29.7 Million USD | -4850.0% |
| 1995 Q4 | -29.7 Million USD | -1880.0% |
| 1995 Q3 | -1.5 Million USD | -400.0% |
| 1994 Q2 | -800 Thousand USD | 94.44% |
| 1994 FY | -600 Thousand USD | 66.67% |
| 1994 Q1 | -14.4 Million USD | -700.0% |
| 1994 Q3 | -800 Thousand USD | 0.0% |
| 1994 Q4 | -600 Thousand USD | 25.0% |
| 1993 Q1 | -16.3 Million USD | -482.14% |
| 1993 Q2 | -16.4 Million USD | -0.61% |
| 1993 Q3 | -16.5 Million USD | -0.61% |
| 1993 Q4 | -1.8 Million USD | 89.09% |
| 1993 FY | -1.8 Million USD | 35.71% |
| 1992 FY | -2.8 Million USD | -16.67% |
| 1992 Q1 | -2.4 Million USD | 0.0% |
| 1992 Q4 | -2.8 Million USD | 81.46% |
| 1992 Q2 | -14.1 Million USD | -487.5% |
| 1992 Q3 | -15.1 Million USD | -7.09% |
| 1991 Q4 | -2.4 Million USD | 0.0% |
| 1991 FY | -2.4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -56098.954% |
| AngioDynamics, Inc. | -70.14 Million USD | 2167.941% |
| AtriCure, Inc. | -9.81 Million USD | 14876.844% |
| Avinger, Inc. | 10.12 Million USD | -14232.955% |
| Azenta, Inc. | -618.47 Million USD | 334.528% |
| BioLife Solutions, Inc. | 7.25 Million USD | -19898.552% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 40.757% |
| Daxor Corporation | 755.65 Thousand USD | -191850.999% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 98773.129% |
| Femasys Inc. | -15.01 Million USD | 9760.181% |
| GlucoTrack, Inc. | -4.29 Million USD | 33863.85% |
| Harvard Bioscience, Inc. | 38.49 Million USD | -3668.498% |
| Hologic, Inc. | 374.4 Million USD | -287.419% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 154.524% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 20712.054% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 28134.306% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 33931.205% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 33931.205% |
| Masimo Corporation | 804 Million USD | -80.41% |
| Microbot Medical Inc. | -2.28 Million USD | 63551.225% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 15216.024% |
| Merit Medical Systems, Inc. | 302.22 Million USD | -379.942% |
| Nephros, Inc. | -2.47 Million USD | 58800.728% |
| NovoCure Limited | 355.42 Million USD | -308.106% |
| NEXGEL, Inc. | 98 Thousand USD | -1479996.939% |
| NEXGEL, Inc. | 98 Thousand USD | -1479996.939% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | -2356.176% |
| OraSure Technologies, Inc. | -276.9 Million USD | 623.828% |
| Pro-Dex, Inc. | 10.91 Million USD | -13187.789% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 4218.268% |
| Predictive Oncology Inc. | -5.87 Million USD | 24802.538% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -47784.033% |
| QuidelOrtho Corporation | 2.49 Billion USD | 41.869% |
| Repligen Corporation | -39.51 Million USD | 3770.374% |
| Sanara MedTech Inc. | 6.64 Million USD | -21728.715% |
| STAAR Surgical Company | -147.2 Million USD | 1085.364% |
| Sharps Technology, Inc. | -3.01 Million USD | 48242.691% |
| Utah Medical Products, Inc. | -92.52 Million USD | 1667.662% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 26.183% |
| Jin Medical International Ltd. | -2.81 Million USD | 51599.765% |